Literature DB >> 26781112

Post-Treatment Controllers: Role in HIV "Cure" Research.

Leslie R Cockerham1, Hiroyu Hatano2, Steven G Deeks3.   

Abstract

Descriptions of individuals who are able to control viral replication in the absence of antiretroviral therapy after receiving short-term therapy early in infection ("post-treatment controllers") has generated excitement and controversy within the field. As with natural or "elite" controllers, these cases provide hope that a long-term remission or "functional cure" might one day be possible. Here, we review what is known and not known about these cases and discuss the immunologic factors that may allow these unique individuals to be maintain viral control and may be important for future curative strategies.

Entities:  

Keywords:  Antiretroviral therapy; HIV infection; HIV latency; HIV viral rebound; Post-treatment controllers; T cell activation

Mesh:

Substances:

Year:  2016        PMID: 26781112     DOI: 10.1007/s11904-016-0296-x

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  74 in total

1.  Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

Authors:  Janet D Siliciano; Joleen Kajdas; Diana Finzi; Thomas C Quinn; Karen Chadwick; Joseph B Margolick; Colin Kovacs; Stephen J Gange; Robert F Siliciano
Journal:  Nat Med       Date:  2003-05-18       Impact factor: 53.440

2.  Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

Authors:  Benjamin Descours; Veronique Avettand-Fenoel; Catherine Blanc; Assia Samri; Adeline Mélard; Virginie Supervie; Ioannis Theodorou; Guislaine Carcelain; Christine Rouzioux; Brigitte Autran
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

3.  Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

Authors:  Vivek Jain; Wendy Hartogensis; Peter Bacchetti; Peter W Hunt; Hiroyu Hatano; Elizabeth Sinclair; Lorrie Epling; Tzong-Hae Lee; Michael P Busch; Joseph M McCune; Christopher D Pilcher; Frederick M Hecht; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

4.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

5.  How a single patient influenced HIV research--15-year follow-up.

Authors:  Heiko Jessen; Todd M Allen; Hendrik Streeck
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

6.  Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.

Authors:  Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

7.  Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Authors:  Cécile Goujard; Marie-Laure Chaix; Olivier Lambotte; Christiane Deveau; Martine Sinet; Julien Guergnon; Valérie Courgnaud; Christine Rouzioux; Jean-François Delfraissy; Alain Venet; Laurence Meyer
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

9.  Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.

Authors:  Ellen Van Gulck; Lotte Bracke; Leo Heyndrickx; Sandra Coppens; Derek Atkinson; Céline Merlin; Alexander Pasternak; Eric Florence; Guido Vanham
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

10.  Short-course antiretroviral therapy in primary HIV infection.

Authors:  Sarah Fidler; Kholoud Porter; Fiona Ewings; John Frater; Gita Ramjee; David Cooper; Helen Rees; Martin Fisher; Mauro Schechter; Pontiano Kaleebu; Giuseppe Tambussi; Sabine Kinloch; Jose M Miro; Anthony Kelleher; Myra McClure; Steve Kaye; Michelle Gabriel; Rodney Phillips; Jonathan Weber; Abdel Babiker
Journal:  N Engl J Med       Date:  2013-01-17       Impact factor: 91.245

View more
  13 in total

1.  Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Authors:  Rebecca T Veenhuis; Abena K Kwaa; Caroline C Garliss; Rachel Latanich; Maria Salgado; Christopher W Pohlmeyer; Christopher L Nobles; John Gregg; Eileen P Scully; Justin R Bailey; Frederic D Bushman; Joel N Blankson
Journal:  JCI Insight       Date:  2018-09-20

2.  HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers.

Authors:  Radwa Sharaf; Guinevere Q Lee; Xiaoming Sun; Behzad Etemad; Layla M Aboukhater; Zixin Hu; Zabrina L Brumme; Evgenia Aga; Ronald J Bosch; Ying Wen; Golnaz Namazi; Ce Gao; Edward P Acosta; Rajesh T Gandhi; Jeffrey M Jacobson; Daniel Skiest; David M Margolis; Ronald Mitsuyasu; Paul Volberding; Elizabeth Connick; Daniel R Kuritzkes; Michael M Lederman; Xu G Yu; Mathias Lichterfeld; Jonathan Z Li
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

3.  Insights into the Impact of CD8+ Immune Modulation on Human Immunodeficiency Virus Evolutionary Dynamics in Distinct Anatomical Compartments by Using Simian Immunodeficiency Virus-Infected Macaque Models of AIDS Progression.

Authors:  Brittany Rife Magalis; David J Nolan; Patrick Autissier; Tricia H Burdo; Kenneth C Williams; Marco Salemi
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 4.  Cure and Long-Term Remission Strategies.

Authors:  Luisa Mori; Susana T Valente
Journal:  Methods Mol Biol       Date:  2022

5.  Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity.

Authors:  Rebecca J Peters; Mario Stevenson
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

Review 6.  Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.

Authors:  Marina Caskey; Florian Klein; Michel C Nussenzweig
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

7.  Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.

Authors:  Evan S Jacobs; Sheila M Keating; Mohamed Abdel-Mohsen; Stuart L Gibb; John W Heitman; Heather C Inglis; Jeffrey N Martin; Jinbing Zhang; Zhanna Kaidarova; Xutao Deng; Shiquan Wu; Kathryn Anastos; Howard Crystal; Maria C Villacres; Mary Young; Ruth M Greenblatt; Alan L Landay; Stephen J Gange; Steven G Deeks; Elizabeth T Golub; Satish K Pillai; Philip J Norris
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

8.  Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy.

Authors:  John M Murray
Journal:  J Virus Erad       Date:  2018-04-01

Review 9.  Towards multiscale modeling of the CD8+ T cell response to viral infections.

Authors:  Subhasish Baral; Rubesh Raja; Pramita Sen; Narendra M Dixit
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2019-02-27

10.  Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV.

Authors:  Leila B Giron; Clovis S Palmer; Qin Liu; Xiangfan Yin; Emmanouil Papasavvas; Radwa Sharaf; Behzad Etemad; Mohammad Damra; Aaron R Goldman; Hsin-Yao Tang; Rowena Johnston; Karam Mounzer; Jay R Kostman; Pablo Tebas; Alan Landay; Luis J Montaner; Jeffrey M Jacobson; Jonathan Z Li; Mohamed Abdel-Mohsen
Journal:  Nat Commun       Date:  2021-06-29       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.